FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Advita Ortho Hit with 7 QS Violations

FDA warns Exactech, doing business as Advita Ortho, about Quality System violations in its production of accessories for the Equinoxe Reverse Shoulder...

latest-news-card-1
Human Drugs

Rosemont Pharma Gets Complete Response on Valacyclovir

FDA posts a 3/5 complete response letter to Rosemont Pharmaceuticals, rejecting the companys NDA for valacyclovir.

latest-news-card-1
Human Drugs

CGMP Issues at Simtra BioPharma Solutions

FDA warns Westphalia, Germany-based Simtra BioPharma Solutions about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

Novo Nordisk PADE Reporting Violations

FDA warns Novo Nordisk in Plainsboro, NJ, about its failure to meet postmarketing adverse drug experience reporting requirements.

latest-news-card-1
Human Drugs

CGMP Violations at Fareva Morton Grove

FDA warns Frances Fareva about CGMP violations in the production of finished drugs at its Morton Grove, IL, manufacturing facility.

latest-news-card-1
Medical Devices

FDA Issues Early Alert on Erbe Flexible Cryoprobes

FDA issues an early alert regarding a potential safety issue with certain Erbe USA Flexible Cryoprobes, following reports that some devices may ruptur...

latest-news-card-1
Marketing

Hims & Hers Super Bowl Ad Hit

The Institute for Safe Medicines calls on FDA, the Federal Trade Commission, and the Department of Justice to take enforcement action against Hims & H...

latest-news-card-1
Marketing

FDA DTC Ad Crackdown Raises Legal Issues: Attorneys

Five Sidley attorneys recommend ways in which drug companies can analyze their direct-to-consumer promotions to see if they are likely to run afoul of...

latest-news-card-1
Biologics

FDA Flags Safety Reporting Lapses at U.K. Clinical Trial Site

FDA cites a U.K.-based clinical research center for failing to promptly report adverse events and for potential falsification of study records during ...

latest-news-card-1
Human Drugs

Vertex Reports Positive Interim Phase 3 Data for Povetacicept

Vertex Pharmaceuticals says an interim analysis of its Phase 3 RAINIER trial showed its experimental therapy povetacicept significantly reduced protei...